Investigator
Danielle L Swaney
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · funded by NIA, NIAID, NINDS
- Companies
- 2
- Grants
- 7
- Non-dilutive funding
- $3.1M
- First award
- Aug 17, 2018
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY57momentum
OncologyGrant-only
- HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY52momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics
$817kJun 1, 2025NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11111785 (opens the source filing in a new tab)
- R01
Aberrant proteomes in tauopathy: revealing functional consequences via multimodal proteomics
$797kJun 1, 2025NIAUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11336351 (opens the source filing in a new tab)
- U54
Core 1 Krogan
$358kJul 15, 2022NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11111408 (opens the source filing in a new tab)
- U54
Core 1 Krogan
$417kJul 15, 2022NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11369928 (opens the source filing in a new tab)
- U54
Core B: Proteomics
$132kSep 1, 2021NINDSICAHN SCHOOL OF MEDICINE AT MOUNT SINAINIH RePORTER · 11170002 (opens the source filing in a new tab)
- U19
CORE 2: Technology Core
$267kAug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11088226 (opens the source filing in a new tab)
- U19
CORE 2: Technology Core
$267kAug 17, 2018NIAIDUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11521634 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources